Data by Company within Biotechnology & Pharmaceuticals Industry
|
|
Marketcap |
Revenues (TTM) |
Net Income (TTM) |
Employees |
Company |
(Millions) |
(Millions) |
(Millions) |
Number |
Amgen Inc |
$ 118,769 |
$ 26,190 |
$ 7,917 |
24,200 |
Intuitive Surgical Inc |
$ 110,652 |
$ 6,431 |
$ 1,336 |
9,793 |
Gilead Sciences Inc |
$ 98,862 |
$ 27,043 |
$ 5,539 |
14,400 |
Edwards Lifesciences Corporation |
$ 50,998 |
$ 5,501 |
$ 1,489 |
15,700 |
Moderna Inc |
$ 50,872 |
$ 15,059 |
$ 4,784 |
2,700 |
Biogen Inc |
$ 44,849 |
$ 10,105 |
$ 3,131 |
9,610 |
Idexx Laboratories Inc |
$ 37,840 |
$ 3,431 |
$ 699 |
10,350 |
Seagen Inc |
$ 36,397 |
$ 2,056 |
$ -649 |
2,700 |
Agilent Technologies inc |
$ 34,063 |
$ 7,040 |
$ 1,351 |
18,100 |
Illumina Inc |
$ 31,824 |
$ 4,584 |
$ -4,404 |
9,800 |
Mettler Toledo International Inc |
$ 29,545 |
$ 3,951 |
$ 887 |
17,800 |
Zimmer Biomet Holdings Inc |
$ 27,998 |
$ 7,108 |
$ 451 |
19,500 |
Align Technology inc |
$ 23,267 |
$ 3,705 |
$ 315 |
22,540 |
Steris Plc |
$ 20,588 |
$ 4,958 |
$ 106 |
16,000 |
Revvity Inc |
$ 14,574 |
$ 3,275 |
$ 1,053 |
16,700 |
Avantor Inc |
$ 13,779 |
$ 7,342 |
$ 618 |
- |
Bio techne Corp |
$ 13,293 |
$ 1,124 |
$ 272 |
3,000 |
Bruker Corporation |
$ 11,156 |
$ 2,621 |
$ 314 |
6,900 |
Bio rad Laboratories Inc |
$ 11,083 |
$ 2,779 |
$ -189 |
7,900 |
Acceleron Pharma inc |
$ 10,892 |
$ 113 |
$ -255 |
450 |
Qiagen N v |
$ 10,423 |
$ 2,985 |
$ 513 |
5,700 |
Repligen Corp |
$ 9,769 |
$ 778 |
$ 168 |
1,170 |
Enzon Pharmaceuticals inc |
$ 9,277 |
$ 1 |
$ 0 |
- |
Neurocrine Biosciences Inc |
$ 9,050 |
$ 1,599 |
$ 64 |
1,000 |
Ortho Clinical Diagnostics Holdings Plc |
$ 8,448 |
- |
$ 54 |
- |
Exelixis Inc |
$ 6,287 |
$ 1,664 |
$ 351 |
566 |
10x Genomics Inc |
$ 6,246 |
$ 505 |
$ -152 |
1,500 |
Lantheus Holdings Inc |
$ 5,881 |
$ 1,027 |
$ -18 |
1,000 |
Quidelortho Corp |
$ 5,800 |
$ 3,328 |
$ 578 |
- |
Msa Safety Incorporated |
$ 5,797 |
$ 1,528 |
$ 180 |
4,800 |
Coherent Corp |
$ 5,459 |
$ 4,325 |
$ -48 |
5,663 |
Crispr Therapeutics Ag |
$ 4,939 |
$ 100 |
$ -524 |
- |
Halozyme Therapeutics Inc |
$ 4,788 |
$ 705 |
$ 182 |
3,011 |
Vaxcyte Inc |
$ 4,418 |
- |
$ -245 |
- |
Ambrx Biopharma Inc |
$ 4,309 |
$ 7 |
$ -68 |
- |
Denali Therapeutics Inc |
$ 4,202 |
$ 138 |
$ 59 |
340 |
Neogen Corporation |
$ 4,192 |
$ 721 |
$ -13 |
1,700 |
Intellia Therapeutics Inc |
$ 3,815 |
$ 53 |
$ -430 |
- |
Vir Biotechnology Inc |
$ 3,459 |
$ 446 |
$ -144 |
- |
Pacific Biosciences Of California Inc |
$ 3,381 |
$ 134 |
$ -321 |
500 |
Krystal Biotech Inc |
$ 3,275 |
- |
$ -135 |
- |
Enovis Corp |
$ 3,104 |
$ 2,067 |
$ -129 |
36 |
Immunovant Inc |
$ 2,622 |
- |
$ -211 |
- |
Revolution Medicines Inc |
$ 2,552 |
$ 35 |
$ -259 |
- |
Beam Therapeutics Inc |
$ 2,483 |
$ 77 |
$ -316 |
- |
Olink Holding Ab publ |
$ 2,389 |
$ 95 |
$ -38 |
267 |
Mesoblast Ltd |
$ 2,329 |
$ 10 |
$ -91 |
- |
Arcellx Inc |
$ 1,963 |
- |
$ -190 |
- |
Myriad Genetics Inc |
$ 1,886 |
$ 695 |
$ -146 |
2,700 |
Iovance Biotherapeutics inc |
$ 1,761 |
- |
$ -412 |
- |
Recursion Pharmaceuticals Inc |
$ 1,738 |
$ 47 |
$ -249 |
- |
Celldex Therapeutics inc |
$ 1,668 |
$ 3 |
$ -119 |
- |
Biocryst Pharmaceuticals Inc |
$ 1,661 |
$ 290 |
$ -226 |
192 |
Establishment Labs Holdings Inc |
$ 1,638 |
$ 170 |
$ -81 |
400 |
Vericel Corporation |
$ 1,637 |
$ 169 |
$ -17 |
- |
Prime Medicine Inc |
$ 1,495 |
- |
$ 0 |
- |
Meridian Bioscience Inc |
$ 1,491 |
$ 324 |
$ 7 |
850 |
Kymera Therapeutics Inc |
$ 1,476 |
$ 40 |
$ -161 |
- |
Springworks Therapeutics Inc |
$ 1,466 |
- |
$ -348 |
- |
Valneva Se |
$ 1,457 |
$ 390 |
$ -82 |
550 |
Relay Therapeutics Inc |
$ 1,412 |
$ 1 |
$ -324 |
- |
Aslan Pharmaceuticals Limited |
$ 1,394 |
$ 3 |
$ -32 |
- |
Replimune Group Inc |
$ 1,332 |
- |
$ -174 |
- |
Immunitybio inc |
$ 1,307 |
$ 1 |
$ -431 |
- |
Avanos Medical Inc |
$ 1,279 |
$ 814 |
$ 44 |
4,100 |
Heska Corporation |
$ 1,245 |
$ 255 |
$ -20 |
542 |
Sana Biotechnology Inc |
$ 1,188 |
- |
$ -271 |
- |
Cytek Biosciences Inc |
$ 1,118 |
$ 166 |
$ -2 |
300 |
Inhibrx Inc |
$ 1,075 |
$ 1 |
$ -163 |
- |
Adaptimmune Therapeutics Plc |
$ 1,040 |
$ 73 |
$ -114 |
- |
Scilex Holding Company |
$ 932 |
- |
$ -53 |
- |
Adma Biologics Inc |
$ 901 |
$ 182 |
$ -48 |
256 |
Regenxbio Inc |
$ 886 |
$ 110 |
$ -270 |
300 |
Allogene Therapeutics Inc |
$ 844 |
$ 0 |
$ -351 |
- |
Quanterix Corp |
$ 840 |
$ 113 |
$ -24 |
359 |
Cadre Holdings inc |
$ 759 |
$ 465 |
$ 23 |
- |
Vectivbio Holding Ag |
$ 737 |
$ 27 |
$ -94 |
- |
Anavex Life Sciences Corp |
$ 734 |
$ 4 |
$ -4 |
- |
Aerie Pharmaceuticals Inc |
$ 729 |
$ 214 |
$ -37 |
259 |
Editas Medicine inc |
$ 725 |
$ 23 |
$ -219 |
- |
Orchard Therapeutics Plc |
$ 720 |
$ 18 |
$ -124 |
- |
Hillevax Inc |
$ 677 |
- |
$ -119 |
- |
Novavax inc |
$ 661 |
$ 1,359 |
$ -1,155 |
370 |
Alector Inc |
$ 633 |
$ 126 |
$ -135 |
155 |
4d Molecular Therapeutics Inc |
$ 598 |
$ 2 |
$ -110 |
- |
Agenus Inc |
$ 584 |
$ 95 |
$ -251 |
- |
Iteos Therapeutics Inc |
$ 555 |
$ 128 |
$ 12 |
97 |
Allovir Inc |
$ 543 |
- |
$ -166 |
- |
Aptose Biosciences Inc |
$ 540 |
- |
$ -44 |
- |
Scholar Rock Holding Corp |
$ 538 |
$ 47 |
$ -166 |
- |
Fate Therapeutics Inc |
$ 536 |
$ 137 |
$ -235 |
208 |
Tenaya Therapeutics Inc |
$ 534 |
- |
$ -124 |
- |
Voyager Therapeutics Inc |
$ 531 |
$ 191 |
$ 99 |
- |
Tarsus Pharmaceuticals Inc |
$ 511 |
$ 17 |
$ -65 |
- |
Outlook Therapeutics Inc |
$ 485 |
- |
$ -57 |
- |
Aura Biosciences Inc |
$ 485 |
- |
$ -63 |
- |
Kodiak Sciences Inc |
$ 484 |
- |
$ -309 |
- |
Humacyte Inc |
$ 432 |
- |
$ -29 |
- |
Coherus Biosciences inc |
$ 426 |
$ 183 |
$ -271 |
650 |
Omega Therapeutics Inc |
$ 425 |
$ 2 |
$ -108 |
- |
Cabaletta Bio Inc |
$ 415 |
- |
$ -56 |
- |
Icosavax Inc |
$ 413 |
$ 1 |
$ -93 |
- |
Compass Therapeutics Inc |
$ 407 |
- |
$ -40 |
- |
Nautilus Biotechnology Inc |
$ 392 |
- |
$ -57 |
- |
Exscientia Plc |
$ 387 |
- |
$ 0 |
- |
Vigil Neuroscience Inc |
$ 385 |
- |
$ -73 |
- |
Bluebird Bio Inc |
$ 384 |
$ 4 |
$ -123 |
- |
Meiragtx Holdings Plc |
$ 374 |
$ 14 |
$ -129 |
- |
Harvard Bioscience Inc |
$ 361 |
$ 115 |
$ -2 |
289 |
Vor Biopharma Inc |
$ 351 |
- |
$ -98 |
- |
Monte Rosa Therapeutics Inc |
$ 349 |
- |
$ -117 |
- |
Sanara Medtech Inc |
$ 321 |
$ 54 |
$ -6 |
- |
Seer Inc |
$ 315 |
$ 16 |
$ -93 |
- |
X4 Pharmaceuticals Inc |
$ 308 |
- |
$ -96 |
- |
Sutro Biopharma Inc |
$ 302 |
$ 75 |
$ -130 |
- |
Oyster Point Pharma Inc |
$ 300 |
$ 20 |
$ -235 |
- |
Vicarious Surgical Inc |
$ 296 |
- |
$ -64 |
- |
Caribou Biosciences Inc |
$ 292 |
$ 15 |
$ -108 |
- |
Nanostring Technologies Inc |
$ 289 |
$ 132 |
$ -161 |
721 |
Acorda Therapeutics Inc |
$ 283 |
$ 118 |
$ -58 |
327 |
Autolus Therapeutics Plc |
$ 280 |
$ 0 |
$ -149 |
- |
Fusion Pharmaceuticals Inc |
$ 279 |
$ 1 |
$ 83 |
- |
Sophia Genetics Sa |
$ 274 |
$ 48 |
$ -87 |
- |
Inogen Inc |
$ 257 |
$ 369 |
$ -90 |
872 |
Ikena Oncology Inc |
$ 251 |
$ 18 |
$ -66 |
- |
Pulse Biosciences Inc |
$ 240 |
$ 3 |
$ -51 |
- |
Innate Pharma Sa |
$ 240 |
$ 65 |
$ -65 |
- |
Eyepoint Pharmaceuticals Inc |
$ 235 |
$ 40 |
$ -102 |
- |
Lineage Cell Therapeutics Inc |
$ 230 |
$ 12 |
$ -24 |
- |
Bionano Genomics Inc |
$ 228 |
$ 30 |
$ -140 |
- |
Checkmate Pharmaceuticals Inc |
$ 227 |
- |
$ -63 |
- |
Sangamo Therapeutics Inc |
$ 220 |
$ 241 |
$ -127 |
411 |
Akoya Biosciences Inc |
$ 213 |
$ 79 |
$ -73 |
- |
Scientific Industries Inc |
$ 209 |
$ 11 |
$ -7 |
739 |
Genfit S a |
$ 209 |
$ 30 |
$ -27 |
194 |
Molecular Partners Ag |
$ 206 |
$ 10 |
$ -64 |
- |
Acumen Pharmaceuticals Inc |
$ 206 |
- |
$ -45 |
- |
Poseida Therapeutics Inc |
$ 205 |
$ 141 |
$ -60 |
- |
La Jolla Pharmaceutical Company |
$ 200 |
$ 46 |
$ 4 |
- |
Century Therapeutics inc |
$ 198 |
$ 6 |
$ -125 |
- |
Standard Biotools Inc |
$ 180 |
$ 97 |
$ -131 |
- |
Sorrento Therapeutics Inc |
$ 179 |
- |
$ 0 |
- |
Dbv Technologies S a |
$ 178 |
- |
$ -100 |
- |
C4 Therapeutics Inc |
$ 177 |
$ 27 |
$ -131 |
- |
Bioatla Inc |
$ 177 |
- |
$ -110 |
- |
Atara Biotherapeutics Inc |
$ 172 |
$ 68 |
$ -229 |
- |
Gamida Cell Ltd |
$ 165 |
- |
$ 79 |
- |
Invivyd Inc |
$ 150 |
- |
$ -176 |
- |
Adverum Biotechnologies Inc |
$ 148 |
$ 2 |
$ -146 |
- |
Inmune Bio Inc |
$ 148 |
$ 0 |
$ -27 |
- |
Freeline Therapeutics Holdings Plc |
$ 141 |
- |
$ -140 |
- |
Jasper Therapeutics Inc |
$ 141 |
- |
$ -50 |
- |
Protalix Biotherapeutics inc |
$ 140 |
$ 41 |
$ -16 |
- |
Athira Pharma Inc |
$ 136 |
- |
$ -102 |
- |
Cidara Therapeutics Inc |
$ 129 |
$ 41 |
$ -9 |
- |
Lixte Biotechnology Holdings Inc |
$ 123 |
- |
$ -7 |
- |
Solid Biosciences Inc |
$ 123 |
$ 15 |
$ -91 |
- |
Vaxart Inc |
$ 122 |
$ 0 |
$ -108 |
- |
Arya Sciences Acquisition Corp Iv |
$ 118 |
- |
$ 1 |
- |
Eargo Inc |
$ 109 |
$ 40 |
$ -149 |
- |
Brainstorm Cell Therapeutics inc |
$ 108 |
- |
$ -24 |
- |
Achieve Life Sciences Inc |
$ 108 |
- |
$ -44 |
- |
Compugen Ltd |
$ 105 |
$ 8 |
$ -34 |
- |
Alpha Teknova Inc |
$ 104 |
$ 39 |
$ -51 |
- |
Talaris Therapeutics Inc |
$ 103 |
- |
$ -78 |
- |
Ocugen Inc |
$ 99 |
- |
$ -81 |
- |
Jounce Therapeutics inc |
$ 97 |
$ 148 |
$ 0 |
125 |
Volitionrx Limited |
$ 96 |
$ 0 |
$ -32 |
- |
Genenta Science S p a |
$ 96 |
- |
$ -9 |
- |
Atyr Pharma Inc |
$ 95 |
$ 10 |
$ -45 |
- |
Lakeland Industries Inc |
$ 92 |
$ 120 |
$ 12 |
1,000 |
Aceragen Inc |
$ 87 |
- |
$ -23 |
- |
Precision Biosciences Inc |
$ 87 |
$ 31 |
$ -109 |
- |
Cellectis S a |
$ 86 |
$ 57 |
$ -125 |
- |
Cognition Therapeutics inc |
$ 86 |
- |
$ -24 |
- |
Collplant Biotechnologies Ltd |
$ 83 |
$ 16 |
$ 0 |
- |
Cue Health Inc |
$ 80 |
$ 329 |
$ -291 |
51 |
Curis Inc |
$ 80 |
$ 10 |
$ -52 |
- |
Cardiff Oncology inc |
$ 78 |
$ 2 |
$ -40 |
- |
Black Diamond Therapeutics Inc |
$ 77 |
- |
$ -87 |
- |
Milestone Scientific Inc |
$ 77 |
$ 9 |
$ -8 |
- |
Mink Therapeutics Inc |
$ 75 |
- |
$ -26 |
- |
Champions Oncology Inc |
$ 75 |
$ 54 |
$ 0 |
- |
Tscan Therapeutics Inc |
$ 75 |
$ 17 |
$ -73 |
- |
Xtant Medical Holdings Inc |
$ 72 |
$ 63 |
$ -8 |
- |
Logicbio Therapeutics Inc |
$ 68 |
$ 11 |
$ -27 |
- |
Elevation Oncology inc |
$ 68 |
- |
$ -95 |
- |
Mymd Pharmaceuticals Inc |
$ 66 |
- |
$ -13 |
- |
Pharmacyte Biotech Inc |
$ 65 |
- |
$ -6 |
- |
Homology Medicines Inc |
$ 63 |
$ 3 |
$ -126 |
- |
In8bio Inc |
$ 63 |
- |
$ -30 |
- |
Dyadic International Inc |
$ 62 |
- |
$ 2,481 |
84 |
Tcr2 Therapeutics Inc |
$ 62 |
- |
$ -163 |
- |
Singular Genomics Systems Inc |
$ 62 |
- |
$ 89 |
- |
Armata Pharmaceuticals Inc |
$ 57 |
$ 5 |
$ -43 |
- |
Renovacor Inc |
$ 56 |
- |
$ -4 |
- |
Passage Bio inc |
$ 55 |
- |
$ -128 |
- |
Taysha Gene Therapies Inc |
$ 54 |
- |
$ -134 |
- |
Quince Therapeutics Inc |
$ 53 |
- |
$ 22 |
- |
Avrobio Inc |
$ 53 |
- |
$ -101 |
- |
Alpha Pro Tech Ltd |
$ 49 |
$ 58 |
$ 5 |
- |
Aligos Therapeutics Inc |
$ 48 |
$ 14 |
$ -83 |
- |
Sab Biotherapeutics Inc |
$ 48 |
$ 13 |
$ -27 |
- |
Surface Oncology Inc |
$ 47 |
$ 31 |
$ -90 |
- |
Eiger Biopharmaceuticals Inc |
$ 44 |
$ 15 |
$ -97 |
- |
Neoleukin Therapeutics Inc |
$ 44 |
- |
$ -58 |
- |
Greenlight Biosciences Holdings Pbc |
$ 44 |
$ 10 |
$ -157 |
- |
Candel Therapeutics Inc |
$ 44 |
$ 0 |
$ -27 |
- |
Rapid Micro Biosystems Inc |
$ 44 |
$ 18 |
$ 15 |
- |
Senti Biosciences Inc |
$ 43 |
$ 6 |
$ -77 |
- |
Biocardia Inc |
$ 40 |
$ 1 |
$ -12 |
- |
Immucell Corp |
$ 40 |
$ 16 |
$ -5 |
- |
Achilles Therapeutics Plc |
$ 39 |
- |
$ -71 |
- |
Aziyo Biologics inc |
$ 38 |
$ 51 |
$ -33 |
- |
Pluri Inc |
$ 37 |
- |
$ -31 |
- |
Rewalk Robotics Ltd |
$ 36 |
$ 6 |
$ -20 |
- |
Casi Pharmaceuticals inc |
$ 33 |
$ 43 |
$ -40 |
- |
Senstar Technologies Ltd |
$ 33 |
$ 36 |
$ 8 |
- |
Evaxion Biotech A |
$ 33 |
- |
$ -23 |
- |
Trinity Biotech Plc |
$ 32 |
$ 75 |
$ -41 |
569 |
Protara Therapeutics Inc |
$ 32 |
- |
$ -64 |
- |
Arca Biopharma Inc |
$ 30 |
- |
$ -8 |
- |
Isoplexis Corporation |
$ 30 |
$ 17 |
$ -106 |
- |
Miromatrix Medical inc |
$ 26 |
$ 1 |
$ -19 |
- |
Oncocyte Corporation |
$ 26 |
$ 6 |
$ -79 |
- |
Zivo Bioscience Inc |
$ 26 |
- |
$ -9 |
2 |
Applied Genetic Technologies Corporation |
$ 26 |
$ 42 |
$ -70 |
- |
Invacare Holdings Corporation |
$ 25 |
$ 706 |
$ -118 |
5,100 |
Aspira Women s Health Inc |
$ 25 |
$ 9 |
$ -24 |
1,433 |
Axcella Health Inc |
$ 24 |
- |
$ -66 |
- |
Entera Bio Ltd |
$ 23 |
- |
$ 0 |
- |
Idera Pharmaceuticals Inc |
$ 23 |
$ 1 |
$ -12 |
- |
Microbot Medical Inc |
$ 21 |
- |
$ -13 |
- |
Erytech Pharma S a |
$ 19 |
- |
$ -60 |
- |
Inhibikase Therapeutics Inc |
$ 19 |
$ 0 |
$ -18 |
- |
Surrozen Inc |
$ 19 |
- |
$ -42 |
- |
Biomerica Inc |
$ 19 |
$ 10 |
$ -7 |
- |
Astrotech Corp |
$ 19 |
$ 0 |
$ -9 |
42 |
Lucira Health Inc |
$ 18 |
$ 212 |
$ -143 |
100 |
Nutriband Inc |
$ 18 |
$ 1 |
$ -3 |
- |
Sqz Biotechnologies Company |
$ 16 |
$ 22 |
$ -69 |
- |
Precipio inc |
$ 16 |
$ 10 |
$ -11 |
- |
Edoc Acquisition Corp |
$ 16 |
$ 0 |
$ -4 |
- |
Eloxx Pharmaceuticals Inc |
$ 15 |
- |
$ -42 |
- |
Tracon Pharmaceuticals Inc |
$ 15 |
$ 11 |
$ -28 |
- |
Organovo Holdings Inc |
$ 15 |
$ 3 |
$ -12 |
- |
Pressure Biosciences Inc |
$ 15 |
$ 2 |
$ -16 |
- |
Finch Therapeutics Group Inc |
$ 14 |
$ 1 |
$ -154 |
- |
Predictive Oncology Inc |
$ 14 |
$ 1 |
$ -26 |
- |
Talis Biomedical Corporation |
$ 13 |
$ 3 |
$ -98 |
- |
Surgalign Holdings Inc |
$ 13 |
$ 78 |
$ -50 |
- |
Myomo Inc |
$ 12 |
$ 15 |
$ -11 |
- |
Titan Pharmaceuticals Inc |
$ 12 |
$ 0 |
$ -9 |
- |
Opthea Limited |
$ 10 |
$ 0 |
$ -45 |
- |
Green Planet Bioengineering Co Ltd |
$ 9 |
- |
$ 0 |
- |
Old Ayala Inc |
$ 8 |
$ 1 |
$ -38 |
- |
Heart Test Laboratories Inc |
$ 8 |
- |
$ 0 |
- |
Conformis inc |
$ 8 |
$ 59 |
$ -44 |
- |
Creative Medical Technology Holdings Inc |
$ 8 |
$ 0 |
$ -10 |
- |
Allena Pharmaceuticals Inc. |
$ 8 |
- |
$ -43 |
- |
Burzynski Research Institute Inc |
$ 7 |
- |
$ -1 |
- |
Cv Sciences Inc |
$ 7 |
$ 16 |
$ -1 |
- |
Palisade Bio Inc |
$ 7 |
- |
$ -13 |
- |
Nanovibronix Inc |
$ 6 |
$ 2 |
$ -6 |
- |
Qrons Inc |
$ 5 |
- |
$ -1 |
- |
Seqll Inc |
$ 5 |
$ 0 |
$ -5 |
- |
Lifeloc Technologies Inc |
$ 5 |
$ 8 |
$ 0 |
- |
Ladrx Corporation |
$ 4 |
- |
$ -13 |
- |
Advanced Biomedical Technologies Inc |
$ 4 |
$ 0 |
$ -1 |
- |
Bionik Laboratories Corp |
$ 4 |
$ 2 |
$ -3 |
- |
Ladrx Corporation |
$ 4 |
- |
$ -12 |
- |
Logicmark Inc |
$ 3 |
$ 11 |
$ -7 |
- |
Kiromic Biopharma Inc |
$ 2 |
- |
$ -33 |
- |
Fresh Tracks Therapeutics Inc |
$ 2 |
$ 7 |
$ -16 |
- |
Clarus Therapeutics Holdings Inc. |
$ 2 |
$ 8 |
$ -23 |
- |
Biondvax Pharmaceuticals Ltd |
$ 2 |
- |
$ -1 |
- |
Htg Molecular Diagnostics Inc |
$ 2 |
$ 6 |
$ -20 |
- |
Rubius Therapeutics Inc |
$ 2 |
- |
$ -180 |
- |
Quotient Limited |
$ 2 |
$ 39 |
$ -139 |
- |
Polarityte Inc |
$ 2 |
$ 3 |
$ -8 |
- |
Windtree Therapeutics Inc |
$ 2 |
$ 1 |
$ -35 |
- |
Peak Bio Inc |
$ 1 |
- |
$ -1 |
- |
Nexien Biopharma Inc |
$ 1 |
- |
$ 0 |
- |
Codiak Biosciences Inc |
$ 1 |
$ 34 |
$ -17 |
- |
Tc Biopharm holdings Plc |
$ 0 |
$ 4 |
$ -1 |
- |
Cannabis Global Inc. |
$ 0 |
$ 4 |
$ -4 |
- |
Gritstone Bio Inc |
$ 0 |
$ 15 |
$ -57 |
- |
Genethera Inc |
$ 0 |
- |
$ -1 |
- |
Health Discovery Corporation |
$ 0 |
$ 2 |
$ -3 |
- |
Genocea Biosciences Inc |
$ 0 |
$ 21 |
$ -37 |
- |
Allied Healthcare Products inc |
$ 0 |
$ 27 |
$ -5 |
- |
Kaleido Biosciences Inc |
$ 0 |
$ 1 |
$ -87 |
- |
Zura Bio Limited |
$ 0 |
- |
$ -5 |
- |
Spk Acquisition Corp |
- |
- |
$ -1 |
- |
Mymetics Corporation |
- |
$ 1 |
$ -7 |
- |
Mosaic Immunoengineering Inc |
- |
- |
$ -2 |
- |
Biontech Se |
- |
$ 540 |
$ 11,528 |
1,700 |
Ginkgo Bioworks Holdings Inc |
- |
$ 390 |
$ -1,719 |
419 |
Avricore Health Inc |
- |
$ 0 |
$ -1 |
- |
Livento Group Inc |
- |
$ 2 |
$ -2 |
8 |
Fennec Pharmaceuticals Inc |
- |
- |
$ -26 |
- |
Cen Biotech Inc |
- |
- |
$ 2 |
- |
Replicel Life Sciences Inc |
- |
- |
$ -1 |
- |
Forma Therapeutics Holdings Inc. |
- |
- |
$ -190 |
- |
Cnbx Pharmaceuticals Inc |
- |
$ 0 |
$ -4 |
- |
Cardio Diagnostics Holdings Inc |
- |
$ 6 |
$ -5 |
- |
Coeptis Therapeutics Holdings Inc |
- |
- |
$ -49 |
- |
Cel sci Corporation |
- |
- |
$ -27 |
- |
Steris Plc |
- |
$ 4,784 |
$ -29 |
14,000 |
United Health Products Inc |
- |
$ 0 |
$ -2 |
- |
Biomx Inc |
- |
- |
$ 27 |
- |
Biotechnology & Pharmaceuticals Industry |
$ 1,001,936 |
$ 182,187 |
$ 17,886 |
295,870 |
Recently Reported Results for Biotechnology & Pharmaceuticals Industry |
Lakeland Industries Inc
Investors, rejoice! The stock market has shown promising growth with Lakeland Industries Inc announcing impressive earnings for the first quarter of 2024. The company's earnings per share have advanced by 28.57% to $0.18 per share compared to $0.14 per share from the previous year, and notably, it has even surpassed its earnings of $0.00 per share from the prior reporting season. Moreover, Lakeland Industries Inc has reported revenue growth by 5.213% from $27.28 million to $28.70 million from the similar reporting season a year before. Though sequentially, revenue fell by -16.901% from $34.54 million, the company has continued to thrive and has reported net profits of $1.320 million, which is a growth of 16.92% from its net earnings of $1.129 million in the first quarter of 2024 a year ago.
|
Steris Plc
Steris Plc, a leading biotechnology and pharmaceuticals company, has announced a significant increase in revenue for the most recent fiscal period. The company reported a year-on-year revenue rise of 311.172% to $2.94 billion, which is an impressive figure. However, the company slipped into a net loss of $-0.60. This news is significant and has caused some concern among investors and stakeholders. Compared to the preceding quarter, the income per share fell from $0.56 per share. On the other hand, revenue doubled by a substantial 322.827% from $696.24 million. In the fourth quarter of 2023, Steris Plc posted a net loss of $-90.386 million, as opposed to the net proceeds of $73.623 million recorded in the same quarter a year before. This decline in profits is concerning and indicates a downward trend.
|
Burzynski Research Institute Inc
As a journalist who closely follows the financial performance of various corporations, I find the latest results from Burzynski Research Institute Inc quite intriguing. This small biotech and pharmaceutical firm has reported an operating deficit of $-0.215998 million for the fourth quarter of 2023. While the company has not yet revealed its revenue figures, it is worth comparing these results with the corresponding period from the previous year. In the fourth quarter of 2022, Burzynski Research Institute Inc had already reported an operating deficit of $-0.131272 million. The fact that the shortfall has further expanded to $-0.216 million in the same quarter of 2023 suggests that the company is going through a turbulent period. However, it's important to note that many businesses face such choppy phases while they try to establish prosperous revenue sources.
|
|
|
|
|
|